Stephen T. Worland - Nov 15, 2023 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Stephen T. Worland
Stock symbol
EFTR
Transactions as of
Nov 15, 2023
Transactions value $
$2,973
Form type
4
Date filed
11/16/2023, 05:30 PM
Previous filing
Aug 14, 2023
Next filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2.97K +5.98K +2.29% $0.50 267K Nov 15, 2023 Direct F1
holding EFTR Common Stock 562K Nov 15, 2023 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.